Abstract
This brief communication describes the findings from a randomised controlled trial in Vietnam that co-administration of measles vaccine (MV) with 10-valent pneumococcal conjugate vaccine (PCV10, Synflorix®, GSK) does not affect the immunogenicity of MV. These findings are most relevant for low- and middle-income countries (LMICs) in Asia considering PCV introduction.
Original language | English |
---|---|
Article number | 76 |
Pages (from-to) | 1-3 |
Number of pages | 3 |
Journal | npj Vaccines |
Volume | 5 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Dec 2020 |